Bicyclic heterocycles as FGFR4 inhibitors
Abstract:
The present disclosure relates to bicyclic heterocycles, and pharmaceutical compositions of the same, that are inhibitors of the FGFR3 and/or FGFR4 enzyme and are useful in the treatment of FGFR-associated diseases.
Public/Granted literature
Information query
Patent Agency Ranking
0/0